Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telaprevir in HIV/HCV Coinfected Patients with Severe Fibrosis or Cirrhosis
NCT01500616Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jun 2012
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of telaprevir in hepatitis C (HCV), sponsored by Janssen Pharmaceutical. Started Jun 2012; status: completed.
02
Drugs
telaprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01500616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01500616.